Abstract
25% since 1972. Reasons for this dramatic increase may include (1) an overall improvement in population life expectancy, (2) benefits arising from cardiovascular surgery, and (3) greater proportion of milder cases due to increased frequency of diagnosis. Medical therapy (including β blockers) was also associated with an increase in probable survival. © 1995 Excerpta Medica, Inc. All rights reserved under the United States, International and Pan-American Copyright Conventions.
Cite
CITATION STYLE
Silverman, D. I., Burton, K. J., Gray, J., Bosner, M. S., Kouchoukos, N. T., Roman, M. J., … Tsipouras, P. (1995). Life expectancy in the Marfan syndrome. The American Journal of Cardiology, 75(2), 157–160. https://doi.org/10.1016/S0002-9149(00)80066-1
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
